Berlusconi family leaving soccer again with sale of relegated Monza to American fund
Fininvest, the Berlusconi's family holding company, announced the deal in a statement Tuesday.
'The transaction provides for an initial transfer of 80% of the shares by this summer, with the remaining 20% to be transferred by June 2026,' it said.
Fininvest purchased Monza in 2018 and oversaw the club's rise from the third division to Serie A. But the club based just outside Milan finished last in the recently concluded Serie A season and was relegated to Serie B.
Fininvest was previously controlled by the late Silvio Berlusconi — the three-time Italian premier who died in 2023. Berlusconi owned AC Milan from 1986 to 2017.
BLV is paying about 30 million euros ($35 million) for Monza, according to the Gazzetta dello Sport. Financial details of the deal were not announced.
___
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
7 minutes ago
Wimbledon: No. 1 Aryna Sabalenka avoids the kind of upset that has happened a lot this year
LONDON -- LONDON (AP) — Aryna Sabalenka was just two points from dropping the opening set of her second-round Wimbledon match three times on Wednesday before asserting herself for a 7-6 (4), 6-4 victory over Marie Bouzkova to avoid the sort of surprise that has sent a group of seeded players home. Four of the top 10 women's seeds failed to make it out of the first round: No. 2 Coco Gauff, No. 3 Jessica Pegula, No. 5 Zheng Qinwen and No. 9 Paula Badosa. In all, a record-tying 23 seeded players — 10 women, 13 men — were gone by the end of Day 2, equaling the most at any Grand Slam event in the past 25 years. 'Of course you're going to know the overall picture. ... I hope it's no upsets anymore in this tournament,' the No. 1-ranked Sabalenka said afterward with a chuckle. "If you know what I mean.' She is a three-time Grand Slam champion, with all of those titles coming on hard courts at the Australian Open or U.S. Open. She also was the runner-up to Gauff at the clay-court French Open last month — drawing criticism from some over her post-match comments, a flap she and Gauff set aside via social media videos last week — but hasn't been past the semifinals on the grass of the All England Club. A year ago, Sabalenka was forced to miss Wimbledon because of an injured shoulder. On Wednesday, the record-breaking heat of the first two days gave way to rain that delayed the start of play on smaller courts for about two hours, along with temperatures that dropped from above 90 degrees Fahrenheit (32 Celsius) to below 68 F (20 C). At Centre Court, the 48th-ranked Bouzkova went ahead 6-5 in the first set with the match's initial service break thanks to a double-fault by Sabalenka. Bouzkova served for that set, and was two points away from it at 30-15 in that game, again at 30-all, then once more at deuce. But on the last such occasion, Sabalenka came through with a forehand volley winner she punctuated with a yell, followed by a down-the-line backhand winner that was accompanied by another shout. 'That was a tough moment," said Sabalenka, who will face 2021 U.S. Open champion Emma Raducanu or 2023 Wimbledon champion Marketa Vondrousova next. 'Until that point, (my) return wasn't great enough to break her serve. I'm really glad ... everything clicked together and I was able to break her back. I kind of like felt a little bit better.' That sent them to a tiebreaker, and from 4-all there, Sabalenka took the next three points, ending the set with a powerful forehand return winner off a 67 mph second serve. In the second set, the only break arrived for a 3-2 lead for Sabalenka, and that was basically that. Sabalenka compiled a 41-17 edge in winners while making only 18 unforced errors in a match that lasted a little more than 1 1/2 hours. Australian Open champion Madison Keys, who is seeded sixth, joined Sabalenka in the third round, beating Olga Danilovic 6-4, 6-2. Other players in action later included 2024 runner-up Jasmine Paolini among the women and two-time defending champion Carlos Alcaraz, Taylor Fritz, Frances Tiafoe among the men. Novak Djokovic, who has won seven of his 24 major championships at Wimbledon will lead off the Centre Court schedule on Day 4 against Britain's Dan Evans at 1:30 p.m. local time (8:30 a.m. ET), followed by Iga Swiatek vs. Caty McNally, and No. 1 Jannik Sinner vs. Aleksandar Vukic.
New York Times
8 minutes ago
- New York Times
Trump Announces Preliminary Trade Pact With Vietnam
President Trump said on Wednesday that the United States had reached a trade deal with Vietnam, one that would roll back some of the punishing tariffs he had issued on Vietnamese products in return for that nation agreeing to open its market to American goods. The preliminary deal will also indirectly affect China, an important trading partner of Vietnam. 'It will be a Great Deal of Cooperation between our two Countries,' Mr. Trump wrote in a post on Truth Social announcing the deal. According to Mr. Trump, the deal imposes a 20 percent tariff on all imports from Vietnam and a 40 percent tariff on any 'transshipping.' That provision is aimed at addressing Trump administration criticisms that countries like Vietnam have become a channel for Chinese manufacturers to bypass U.S. tariffs and funnel goods into the United States. Which products would fall under the higher tariff rate is unclear. It could refer to goods imported to the United States from Vietnam that actually originated in China. But it could also apply to Vietnamese products that use a certain amount of Chinese parts. The deal could include a lower tariff on goods that are made in Vietnam with fewer Chinese parts and materials, and a higher tariff rate for Vietnamese goods that contain many Chinese components. Vietnam was soon scheduled to face a 46 percent tariff rate as part of the 'reciprocal' tariffs that the Trump administration unveiled on April 2. Want all of The Times? Subscribe.
Yahoo
9 minutes ago
- Yahoo
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy
Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Commercial Health Benefits, Charles Kendrick, sold US$3.2m worth of shares at a price of US$432 per share. That means that an insider was selling shares at around the current price of US$396. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern. Elevance Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Over the last three months, we've seen significant insider selling at Elevance Health. Specifically, Executive VP & CFO Mark Kaye ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain. For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$103m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. An insider hasn't bought Elevance Health stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
